General

1. Anon. Antifungal drugs. Med Lett Treatment Guidelines 2009;7:95-102.
2. Fisher JF.  Infections - epidemiology, pathogenesis, diagnoses, and treatment:  Executive summary.  Clin Infect Dis 2011;52:429-32.
3. Limper AH, Knox KS, Sarosi GA et al.  An official American Thoracic Society statement:  treatment of fungal infections in adult pulmonary and critical care patients.  Am J Respir Crit Care Med 2011;183:96-128.
4. Pauw B, Walsh TJ, Donnelly JP, et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.  Clin Infect Dis 2008;46:1813-21.
5. Schelenz S, Barnes RA, Barton RC, et al.  British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases.  Lancet Infect Dis 2015 http://dx.doi.org/10.1016/S1473-3099(15)70006-X
6. Sheehan DJ, Hitchcock CA, Sibley CM.  Current and emerging azole antifungal agents.  Clin Microbiol Rev 1999;12:40-79.
   Sobel JD.  Practice guidelines for the treatment of fungal infections.  Clin Infect Dis 2000;30:652.